the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(CIFMS)[2021-I2M-1-017]and[2021-I2M-C&T-B-080];Haihe Laboratory of Cell Ecosystem Innovation Fund[HH22KYZX0036].
Invasive fungal diseases(IFDs)are major and lethal infectious complications for patients with neutropenia after chemotherapy.Prophylaxis with intravenous and oral suspended itraconazole(200 mg Q12h intravenously×2 da...
This study was supported by Grant 18JCYBJC41200 of Tianjin Municipal Science and Technology Commission Grant.
Purpureocillium lilacinum(P lilacinum)is a rare pathogenic fungus,which mainly involves immunocompromised individuals.Here,we report a case of complicated multiple-organ infections involving skin,lungs,and spleen in a...
funded by the 2020 Xinglin Scholars Scientific Research Promotion Plan of Chengdu University of Traditional Chinese Medicine(QNXZ2020007);the Hundred Talents Plan Project of Hospital of Chengdu University of Traditional Chinese Medicine(20-Q07).
Background:Pulmonary mucormycosis(PM)is rare condition,which is difficult to diagnose and has a high mortality rate.Currently,there is a lack of effective drugs,with few side effects,to treat PM.There have been a few ...
To the Editor:A 52-year-old man presented with fever and a painful ulcer on the right thigh for 10 days.The patient had acute lymphoblastic leukemia for 2 years.Two months ago,the patient developed cough and expectora...
The objective of this study was to investigate the probability of target attainment of various posaconazole dosing regimens against Mucorales species in patients with mucormycosis. According to pharmacokinetic/pharmac...
Invasive fungal infections (IFI) have recently become increasingly more prevalent, resulting in an increased risk of morbidity and mortality. Both Candida spp. and Aspergillus spp. are major causes of IFI. In this stu...
Importance:Pulmonary mucormycosis is life threatening and carries a poor prognosis.Identification of factors that improve prognosis is urgently necessary.Objective:To analyze the clinical features and outcomes of pulm...
supported by the grants Red de Investigation Colaborativa en Enfermedades Tropicales RICET(project no.RD16/0027/0001 of the programme of Redes Temáticas de Investigación Cooperativa,FIS),Spanish Ministry of Health,Madrid,Spain;PI13/00490“Protozoosis Emergentes por Amebas de Vida Libre:Aislamiento,Caracterización,Nuevas Aproximaciones Terapéuticas y Traslación Clínica de los Resultados”from the Instituto de Salud Carlos III.IS;supported by the Agustín de Betancourt Programme;supported by Ayudas Plan Propio de la Universidad de La Laguna 2018(proyectos puente I+D+i);supported by PI18/01380 from Instituto de Salud Carlos III and FEDER,Spain and CTQ2014-55888-C03-01/R(MINECO).MRB:RICET[RD16/0027/0001 project,from Programa Redes Temáticas de Investigación Cooperativa,FIS(Ministerio Español de Salud,Madrid,Spain).
Objective: To evaluate the combination of several statins(atorvastatin, fluvastatin and simvastatin) and azoles(voriconazole, posaconazole and itraconazole) against Acanthamoeba spp. Methods: The efficiency of the dif...
BACKGROUND Posaconazole is a widely used azole antifungal agent, and posaconazole-associated severe hyperbilirubinemia is usually rare in clinical practice. We herein report a 58-year-old male with acute myeloid leuke...
A stability-indicating UPLC method has been developed and validated for the determination of related substances of Posaconazole with its four related substances (Hydroxytriazole, Tosylated compound, Deshydroxy posacon...